Kosuke Aritake
International Institute of Minnesota
10 Papers
18 Citations
Kosuke Aritake is an academic researcher from International Institute of Minnesota. The author has contributed to research in topics: Crocin & Homologous recombination. The author has an hindex of 3, co-authored 10 publications.
Chat about Author
Papers
Patent
Method for detecting muscle degenerative diseases, and method for determining therapeutic efficacy on the diseases
Yoshihiro Urade,Kosuke Aritake,Toshihiko Maruyama,Shinya Kamauchi,Shin Ichi Takeda,Akinori Nakamura +5 more
- 08 Mar 2010
TL;DR: In this paper, the therapeutic efficacy of a therapeutic agent and/or a therapy method for the diseases can be determined by measuring 11,15dioxo-9.alpha.-hydroxy-2,3,4,5-tranorprostan-1,20dioic acid (referred to as "Tetranor-PGDM", hereinbelow) in a sample isolated from a subject.
5
Patent
Method for diagnosis of severity and prediction of recurrence in eosinophilic inflammatory disease
Yoshihiro Granshitio-Shimogamo-Shikisaikan Urade,Naomi Eguchi,Kosuke Aritake,Sawako Hyo,Hiroshi Takenaka,Ryo Kawata +5 more
- 17 May 2006
TL;DR: A method for diagnosis of the severity of a condition in an eosinophilic inflammatory disease such as nasal polyp or for prediction of the recurrence of the disease was proposed in this paper.
4
Patent
Sleep improvement agent and sedative and their use
Yoshihiro Urade,Zhi-Li Huang,Kosuke Aritake,Naomi Matsumoto,Masaki Mika,Masayama Yukihiro,Hiroyuki Tanaka +6 more
- 08 Dec 2011
TL;DR: In this article, a sleep improvement agent and a sedative containing crocin expressed by chemical formula (I) as an effective component are used for the administration of the crocin in 2.5 to 20 mg/kg body weight.
3
Patent
Novel glycosylated compound of crocin, method for producing same, and use for same
Yoshihiro Urade,裏出 良博,Zhi-Li Huang,志力 黄,Kosuke Aritake,浩介 有竹,Yukihiro Shoyama,正山 征洋,Takashi Kometani,米谷 俊 +9 more
- 16 May 2013
TL;DR: In this article, a method for the production of glycosylated crocin compounds is described. But this method is not suitable for the use of crocin. And it cannot be used for the extraction of new uses for glycosyclic compounds.
2
Patent
Mouse deleted in hematopoietic forming organ type prostaglandin d synthetase gene and examination method using the mouse
Yoshihiro Urade,Kosuke Aritake,Naomi Eguchi,Masako Taniike,Mori Ikuko +4 more
- 05 Aug 2003
TL;DR: In this paper, a method for examining various pharmacodynamic substances using the mouse deleted in the gene is provided, which is an offspring individual of chimera mouse produced by developing an initial embryo into which a mouse embryonic stem cell having a hematopoietic forming organ type prostaglandin D synthetase gene of genome DNA in which its exon II is subjected to homologous recombination in a variant sequence substituted with neomycin-resistant gene into an individual in a female mouse body.
2